Concepts and classification of neurodegenerative diseases
- PMID: 28987178
- DOI: 10.1016/B978-0-12-802395-2.00021-3
Concepts and classification of neurodegenerative diseases
Abstract
Neurodegenerative diseases are disorders characterized by progressive loss of neurons associated with deposition of proteins showing altered physicochemical properties in the brain and in peripheral organs. Molecular classification of neurodegenerative disease is protein-based. This emphasizes the role of protein-processing systems in the pathogenesis. The most frequent proteins involved in the pathogenesis of neurodegenerative diseases are amyloid-β, prion protein, tau, α-synuclein, TAR-DNA-binding protein 43kDa, and fused-in sarcoma protein. There are further proteins associated mostly with hereditary disorders such as proteins encoded by genes linked to trinucleotide repeat disorders, neuroserpin, ferritin, and familial cerebral amyloidoses. The clinical presentations are defined by the distinct involvement of functional systems and do not necessarily indicate the molecular pathologic background. Seeding of pathologic proteins and hierarchic involvement of anatomic regions is commonly seen in neurodegenerative diseases. Overlap of neurodegenerative diseases and combinations of different disorders is frequent. Translation of neuropathologic categories of neurodegenerative diseases into in vivo detectable biomarkers is only partly achieved but intensive research is performed to reach this goal.
Keywords: biomarker; classification; molecular pathology; neurodegenerative disease; proteinopathy.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Current concepts and molecular pathology of neurodegenerative diseases.Pathology. 2025 Mar;57(2):178-190. doi: 10.1016/j.pathol.2024.10.006. Epub 2024 Nov 14. Pathology. 2025. PMID: 39672768 Review.
-
Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.Acta Neuropathol Commun. 2021 Apr 8;9(1):64. doi: 10.1186/s40478-021-01171-0. Acta Neuropathol Commun. 2021. PMID: 33832546 Free PMC article.
-
Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.Int J Mol Sci. 2016 Feb 2;17(2):189. doi: 10.3390/ijms17020189. Int J Mol Sci. 2016. PMID: 26848654 Free PMC article. Review.
-
Protein Pathologies in Oligodendroglia in Neurodegenerative Diseases.Adv Neurobiol. 2025;43:407-432. doi: 10.1007/978-3-031-87919-7_14. Adv Neurobiol. 2025. PMID: 40500505 Review.
-
Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics.Acta Neuropathol. 2010 Apr;119(4):389-408. doi: 10.1007/s00401-010-0658-1. Epub 2010 Mar 3. Acta Neuropathol. 2010. PMID: 20198481 Review.
Cited by
-
Roles and Mechanisms of Axon-Guidance Molecules in Alzheimer's Disease.Mol Neurobiol. 2021 Jul;58(7):3290-3307. doi: 10.1007/s12035-021-02311-2. Epub 2021 Mar 5. Mol Neurobiol. 2021. PMID: 33675023 Review.
-
Omega-3 Fatty Acids as Druggable Therapeutics for Neurodegenerative Disorders.CNS Neurol Disord Drug Targets. 2019;18(10):735-749. doi: 10.2174/1871527318666191114093749. CNS Neurol Disord Drug Targets. 2019. PMID: 31724519 Free PMC article. Review.
-
Exploration of the Shared Molecular Mechanisms between COVID-19 and Neurodegenerative Diseases through Bioinformatic Analysis.Int J Mol Sci. 2023 Mar 2;24(5):4839. doi: 10.3390/ijms24054839. Int J Mol Sci. 2023. PMID: 36902271 Free PMC article.
-
Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments.Int J Mol Sci. 2019 Apr 12;20(8):1829. doi: 10.3390/ijms20081829. Int J Mol Sci. 2019. PMID: 31013856 Free PMC article. Review.
-
Psychosocial Basis of Human Sufferings and Poverty in Patients with Neurological and Psychiatric Disorders.Med Res Arch. 2023 May;11(5):3919. doi: 10.18103/mra.v11i5.3919. Epub 2023 May 20. Med Res Arch. 2023. PMID: 37641666 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical